LIVIVO - Search results -

Search results

Result 1 - 10 of total 60

Search options

Article ; Online: Public health priorities for the Gulf states.

Alfawaz, Rasha / Alhumud, Raghad / Amato-Gauci, Andrew Joseph / Penttinen, Pasi

The International journal of health planning and management

2024

Abstract: The newly established Gulf Center for Disease Prevention and Control (Gulf CDC) has to identify priorities to tackle in the first 2 years of operation. A rapid situational assessment involving a selected sample of national stakeholders, an objective ... ...

Abstract	The newly established Gulf Center for Disease Prevention and Control (Gulf CDC) has to identify priorities to tackle in the first 2 years of operation. A rapid situational assessment involving a selected sample of national stakeholders, an objective study of the strengths and gaps in the national public health programmes and a study estimating the burden of the main disease/risk factors were carried out. The findings of an objective ranking survey, followed by consensus discussion in an in-person meeting for senior Gulf states' experts, were combined with the evidence available from the previous three studies to result in a short list of the most pressing priority topics for the Gulf CDC to tackle. Both communicable (lead priorities: antimicrobial resistance and immunisation) and non-communicable diseases (leads: cardiovascular disease, then cancer, diabetes, and mental health) are the consensus priorities. Also, the risks associated with non-communicable diseases (high BMI, blood sugar, high blood pressure) and unhealthy lifestyle (poor diet, low physical activity and tobacco use) were also highlighted as top priorities to tackle.
Language	English
Publishing date	2024-03-07
Publishing country	England
Document type	Journal Article
ZDB-ID	632786-2
ISSN	1099-1751 ; 0749-6753
ISSN (online)	1099-1751
ISSN	0749-6753
DOI	10.1002/hpm.3797
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.B 2897: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Details ▾

Article ; Online: Comparative Performance Evaluation of the Public Health Surveillance Systems in 6 Gulf Cooperation Countries: Cross-sectional Study.

Albali, Nawaf / Almudarra, Sami / Al-Farsi, Yahya / Alarifi, Abdullah / Al Wahaibi, Adil / Penttinen, Pasi

JMIR formative research

2023 Volume 7, Page(s) e41269

Abstract: Background: Evaluating public health surveillance systems is important to ensure that events of public health importance are appropriately monitored. Evaluation studies based on the Centers for Disease Control and Prevention (CDC) guidelines have been ... ...

Abstract	Background: Evaluating public health surveillance systems is important to ensure that events of public health importance are appropriately monitored. Evaluation studies based on the Centers for Disease Control and Prevention (CDC) guidelines have been used to appraise surveillance systems globally. Previous evaluation studies undertaken in member countries of the Gulf Cooperation Council (GCC) were limited to specific illnesses within a single nation. Objective: We aimed to evaluate public health surveillance systems in GCC countries using CDC guidelines and recommend necessary improvements to enhance these systems. Methods: The CDC guidelines were used for evaluating the surveillance systems in GCC countries. A total of 6 representatives from GCC countries were asked to rate 43 indicators across the systems' level of usefulness, simplicity, flexibility, acceptability, sensitivity, predictive value positive, representativeness, data quality, stability, and timeliness. Descriptive data analysis and univariate linear regression analysis were performed. Results: All surveillance systems in the GCC covered communicable diseases, and approximately two-thirds (4/6, 67%, 95% CI 29.9%-90.3%) of them covered health care-associated infections. The mean global score was 147 (SD 13.27). The United Arab Emirates scored the highest in the global score with a rating of 167 (83.5%, 95% CI 77.7%-88.0%), and Oman obtained the highest scores for usefulness, simplicity, and flexibility. Strong correlations were observed between the global score and the level of usefulness, flexibility, acceptability, representativeness, and timeliness, and a negative correlation was observed between stability and timeliness score. Disease coverage was the most substantial predictor of the GCC surveillance global score. Conclusions: GCC surveillance systems are performing optimally and have shown beneficial outcomes. GCC countries must use the lessons learned from the success of the systems of the United Arab Emirates and Oman. To maintain GCC surveillance systems so that they are viable and adaptable to future potential health risks, measures including centralized information exchange, deployment of emerging technologies, and system architecture reform are necessary.
Language	English
Publishing date	2023-04-05
Publishing country	Canada
Document type	Journal Article
ISSN	2561-326X
ISSN (online)	2561-326X
DOI	10.2196/41269
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Letter to the editor: Just a coincidence? Two severe human cases due to swine influenza (SIV) A(H1N1)v in Europe, October 2016.

Adlhoch, Cornelia / Penttinen, Pasi

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

2017 Volume 22, Issue 10

Language	English
Publishing date	2017-03-09
Publishing country	Sweden
Document type	Letter
ZDB-ID	1338803-4
ISSN	1560-7917 ; 1025-496X
ISSN (online)	1560-7917
ISSN	1025-496X
DOI	10.2807/1560-7917.ES.2017.22.10.30478
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 5066: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Incidence, Severity and Impact of Influenza: a joint meeting organised by the ISIRV Epidemiology Group and ECDC, Stockholm, 2019.

Rath, Barbara / Penttinen, Pasi

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

2016 Volume 24, Issue 23

MeSH term(s)	Congresses as Topic ; Humans ; Incidence ; Influenza, Human/epidemiology ; Influenza, Human/prevention & control ; Pandemics/prevention & control ; Public Health Surveillance ; Respiratory Tract Infections/epidemiology ; Respiratory Tract Infections/prevention & control ; Severity of Illness Index ; Societies, Medical ; Sweden
Keywords	covid19
Language	English
Publishing date	2016-05-10
Publishing country	Sweden
Document type	Journal Article
ZDB-ID	1338803-4
ISSN	1560-7917 ; 1025-496X
ISSN (online)	1560-7917
ISSN	1025-496X
DOI	10.2807/1560-7917.ES.2019.24.23.1900348
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 5066: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated influenza vaccines: an observational bias or a technical challenge?

Penttinen, Pasi M / Friede, Martin H

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

2016 Volume 21, Issue 38

MeSH term(s)	Humans ; Influenza A Virus, H1N1 Subtype/immunology ; Influenza Vaccines/immunology ; Influenza, Human/prevention & control ; Vaccines, Attenuated/immunology
Chemical Substances	Influenza Vaccines ; Vaccines, Attenuated
Language	English
Publishing date	2016-09-29
Publishing country	Sweden
Document type	Editorial
ZDB-ID	1338803-4
ISSN	1560-7917 ; 1025-496X
ISSN (online)	1560-7917
ISSN	1025-496X
DOI	10.2807/1560-7917.ES.2016.21.38.30350
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 5066: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Author's reply: Regarding the editorial by Penttinen and Friede.

Penttinen, Pasi M / Friede, Martin H

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

2016 Volume 21, Issue 40

MeSH term(s)	Humans ; Influenza Vaccines ; Influenza, Human
Chemical Substances	Influenza Vaccines
Language	English
Publishing date	2016-10-17
Publishing country	Sweden
Document type	Letter ; Comment
ZDB-ID	1338803-4
ISSN	1560-7917 ; 1025-496X
ISSN (online)	1560-7917
ISSN	1025-496X
DOI	10.2807/1560-7917.ES.2016.21.40.30367
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 5066: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: ECDC expert opinion on efficacy and effectiveness of neuraminidase inhibitors published for public consultation.

Penttinen, Pasi / Catchpole, Mike

Influenza and other respiratory viruses

2016 Volume 10, Issue 3, Page(s) 152–153

MeSH term(s)	Antiviral Agents/therapeutic use ; Clinical Trials as Topic ; Enzyme Inhibitors/therapeutic use ; European Union ; Expert Testimony ; Health Policy ; Humans ; Influenza, Human/drug therapy ; Meta-Analysis as Topic ; Neuraminidase/antagonists & inhibitors ; Treatment Outcome ; Zanamivir/therapeutic use
Chemical Substances	Antiviral Agents ; Enzyme Inhibitors ; Neuraminidase (EC 3.2.1.18) ; Zanamivir (L6O3XI777I)
Language	English
Publishing date	2016-05
Publishing country	England
Document type	Editorial
ZDB-ID	2274538-5
ISSN	1750-2659 ; 1750-2640
ISSN (online)	1750-2659
ISSN	1750-2640
DOI	10.1111/irv.12377
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Full text

In stock of ZB MED Cologne/Königswinter

Zs.A 6568: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Protective Measures for Humans against Avian Influenza A(H5N8) Outbreaks in 22 European Union/European Economic Area Countries and Israel, 2016-17.

Adlhoch, Cornelia / Dabrera, Gavin / Penttinen, Pasi / Pebody, Richard

Emerging infectious diseases

2018 Volume 24, Issue 10, Page(s) 1–8

Abstract: We sought to better understand national approaches for managing potential human health risks during outbreaks of infection with avian influenza A(H5N8) virus during 2016-17. Twenty-three countries in the Union/European Economic Area and Israel ... ...

Abstract	We sought to better understand national approaches for managing potential human health risks during outbreaks of infection with avian influenza A(H5N8) virus during 2016-17. Twenty-three countries in the Union/European Economic Area and Israel participated in this study. Risk to the general public was assessed as low in 18 countries and medium in 1 country. Of 524 exposed persons identified, 274 were passively monitored and 250 were actively monitored. Of 29 persons tested, all were negative for H5N8 virus. Vaccination and antiviral drug recommendations varied across countries. A high level of personal protection was recommended although a low risk was assessed. No transmission of this virus to humans was identified.
MeSH term(s)	Animals ; Bird Diseases/epidemiology ; Bird Diseases/virology ; Birds/virology ; Disease Outbreaks ; Environmental Exposure ; Europe/epidemiology ; European Union ; Geography, Medical ; History, 21st Century ; Humans ; Influenza A Virus, H5N8 Subtype/classification ; Influenza, Human/epidemiology ; Influenza, Human/history ; Influenza, Human/prevention & control ; Influenza, Human/virology ; Israel/epidemiology ; Population Surveillance ; Vaccination
Language	English
Publishing date	2018-10-17
Publishing country	United States
Document type	Historical Article ; Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't
ZDB-ID	1380686-5
ISSN	1080-6059 ; 1080-6040
ISSN (online)	1080-6059
ISSN	1080-6040
DOI	10.3201/eid2410.180269
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 4778: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Systematic review of seroprevalence of SARS-CoV-2 antibodies and appraisal of evidence, prior to the widespread introduction of vaccine programmes in the WHO European Region, January-December 2020.

Vaughan, Aisling / Duffell, Erika / Freidl, Gudrun S / Lemos, Diogo Simão / Nardone, Anthony / Valenciano, M / Subissi, Lorenzo / Bergeri, Isabel / K Broberg, Eeva / Penttinen, Pasi / Pebody, Richard / Keramarou, Maria

BMJ open

2023 Volume 13, Issue 11, Page(s) e064240

Abstract: Objectives: Systematic review of SARS-CoV-2 seroprevalence studies undertaken in the WHO European Region to measure pre-existing and cumulative seropositivity prior to the roll out of vaccination programmes.: Design: A systematic review of the ... ...

Abstract	Objectives: Systematic review of SARS-CoV-2 seroprevalence studies undertaken in the WHO European Region to measure pre-existing and cumulative seropositivity prior to the roll out of vaccination programmes. Design: A systematic review of the literature. Data sources: We searched MEDLINE, EMBASE and the preprint servers MedRxiv and BioRxiv in the WHO 'COVID-19 Global literature on coronavirus disease' database using a predefined search strategy. Articles were supplemented with unpublished WHO-supported Unity-aligned seroprevalence studies and other studies reported directly to WHO Regional Office for Europe and European Centre for Disease Prevention and Control. Eligibility criteria: Studies published before the widespread implementation of COVID-19 vaccination programmes in January 2021 among the general population and blood donors, at national and regional levels. Data extraction and synthesis: At least two independent researchers extracted the eligible studies; a third researcher resolved any disagreements. Study risk of bias was assessed using a quality scoring system based on sample size, sampling and testing methodologies. Results: In total, 111 studies from 26 countries published or conducted between 1 January 2020 and 31 December 2020 across the WHO European Region were included. A significant heterogeneity in implementation was noted across the studies, with a paucity of studies from the east of the Region. Sixty-four (58%) studies were assessed to be of medium to high risk of bias. Overall, SARS-CoV-2 seropositivity prior to widespread community circulation was very low. National seroprevalence estimates after circulation started ranged from 0% to 51.3% (median 2.2% (IQR 0.7-5.2%); n=124), while subnational estimates ranged from 0% to 52% (median 5.8% (IQR 2.3%-12%); n=101), with the highest estimates in areas following widespread local transmission. Conclusions: The low levels of SARS-CoV-2 antibody in most populations prior to the start of vaccine programmes underlines the critical importance of targeted vaccination of priority groups at risk of severe disease, while maintaining reduced levels of transmission to minimise population morbidity and mortality.
MeSH term(s)	Humans ; COVID-19 ; SARS-CoV-2 ; COVID-19 Vaccines ; Seroepidemiologic Studies ; World Health Organization
Chemical Substances	COVID-19 Vaccines
Language	English
Publishing date	2023-11-06
Publishing country	England
Document type	Systematic Review ; Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	2599832-8
ISSN	2044-6055 ; 2044-6055
ISSN (online)	2044-6055
ISSN	2044-6055
DOI	10.1136/bmjopen-2022-064240
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Dominant influenza A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and 2017/18 seasons, respectively.

Adlhoch, Cornelia / Snacken, René / Melidou, Angeliki / Ionescu, Silviu / Penttinen, Pasi

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

2018 Volume 23, Issue 13

Abstract: We use surveillance data to describe influenza A and B virus circulation over two consecutive seasons with excess all-cause mortality in Europe, especially in people aged 60 years and older. Influenza A(H3N2) virus dominated in 2016/17 and B/Yamagata in ... ...

Abstract	We use surveillance data to describe influenza A and B virus circulation over two consecutive seasons with excess all-cause mortality in Europe, especially in people aged 60 years and older. Influenza A(H3N2) virus dominated in 2016/17 and B/Yamagata in 2017/18. The latter season was prolonged with positivity rates above 50% among sentinel detections for at least 12 weeks. With a current west-east geographical spread, high influenza activity might still be expected in eastern Europe.
MeSH term(s)	Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Disease Outbreaks ; Europe/epidemiology ; Female ; Humans ; Infant ; Infant, Newborn ; Influenza A Virus, H3N2 Subtype/isolation & purification ; Influenza B virus/isolation & purification ; Influenza, Human/diagnosis ; Influenza, Human/mortality ; Influenza, Human/virology ; Intensive Care Units/statistics & numerical data ; Male ; Middle Aged ; Population Surveillance/methods ; Seasons ; Sentinel Surveillance ; Severity of Illness Index ; Young Adult
Language	English
Publishing date	2018-03-19
Publishing country	Sweden
Document type	Journal Article
ZDB-ID	1338803-4
ISSN	1560-7917 ; 1025-496X
ISSN (online)	1560-7917
ISSN	1025-496X
DOI	10.2807/1560-7917.ES.2018.23.13.18-00146
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 5066: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

To top

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito